Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The diagnostic accuracy of EUS for detection of the liver tumors (primary and metastatic) remains unknown. To compare the accuracy of the EUS and CT scan for detection of the primary and metastatic carcinoma of the liver.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2004
Shorter than P25 for phase_2 hepatocellular-carcinoma
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2006
CompletedFirst Submitted
Initial submission to the registry
February 10, 2006
CompletedFirst Posted
Study publicly available on registry
February 13, 2006
CompletedJune 7, 2006
January 1, 2006
February 10, 2006
June 5, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To compare the accuracy of the EUS and CT scan for detection of the primary and metastatic carcinoma of the liver.
Secondary Outcomes (6)
Secondary:
Determine the diagnostic yield of fine needle aspiration using EUS (EUS-FNA) in patients with suspected liver metastasis on EUS examination.
Compare the accuracy of the PET scan with EUS for the detection of the liver metastases.
Determine the safety of EUS-FNA in subjects with liver lesions.
Impact of the EUS on the management of the hepatocellular carcinoma
- +1 more secondary outcomes
Interventions
Eligibility Criteria
You may qualify if:
- Patients with newly diagnosed colon, pancreatic, esophageal, lung, gastric cancer and patient with hepatitis C or B with elevated levels of alpha-fetoprotein or radiological findings suggestive of mass in the liver.
You may not qualify if:
- Advanced heart or lung disease that precludes conscious sedation
- Liver failure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Central Texas Veterans health Care System
Temple, Texas, 76504, United States
Related Publications (2)
Singh P, Mukhopadhyay P, Bhatt B, Patel T, Kiss A, Gupta R, Bhat S, Erickson RA. Endoscopic ultrasound versus CT scan for detection of the metastases to the liver: results of a prospective comparative study. J Clin Gastroenterol. 2009 Apr;43(4):367-73. doi: 10.1097/MCG.0b013e318167b8cc.
PMID: 18981929DERIVEDSingh P, Erickson RA, Mukhopadhyay P, Gopal S, Kiss A, Khan A, Ulf Westblom T. EUS for detection of the hepatocellular carcinoma: results of a prospective study. Gastrointest Endosc. 2007 Aug;66(2):265-73. doi: 10.1016/j.gie.2006.10.053. Epub 2007 Jun 1.
PMID: 17543307DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pankaj Singh, MD
Central Texas Veterans Health Care System
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 10, 2006
First Posted
February 13, 2006
Study Start
July 1, 2004
Study Completion
January 1, 2006
Last Updated
June 7, 2006
Record last verified: 2006-01